Bayer Cropscience India Limited (IN:BAYERCROP)
:BAYERCROP
Top Page
Bayer Cropscience India Limited
(BAYERCROP)
Select Model
Select Model
Rating:60Neutral
Price Target:
₹4,725.00
▲(4.80% Upside)
Action:ReiteratedDate:11/12/25
Bayer Cropscience India Limited receives an overall stock score of 60, primarily driven by solid financial performance with a strong balance sheet and stable profitability. However, bearish technical indicators reflecting a downward price trend and a high P/E ratio signaling potential overvaluation weigh on the score. Investors should monitor cash flow trends and market momentum for future developments.
Positive Factors
Strong Balance Sheet
A robust balance sheet with low leverage enhances financial stability and flexibility, allowing for strategic investments and resilience against economic fluctuations.
Negative Factors
Declining Profit Margins
Decreasing profit margins suggest rising costs or pricing pressures, which could impact profitability and require strategic adjustments to maintain competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Balance Sheet
A robust balance sheet with low leverage enhances financial stability and flexibility, allowing for strategic investments and resilience against economic fluctuations.
Read all positive factors
Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)
Market Cap
₹215.93B
Dividend Yield1.57%
Average Volume (3M)2.83K
Price to Earnings (P/E)53.5
Beta (1Y)0.97
Revenue Growth8.92%
EPS Growth5.06%
CountryIN
Employees1,317
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)21.30
Shares Outstanding44,942,093
10 Day Avg. Volume4,614
30 Day Avg. Volume2,834
Financial Highlights & Ratios
PEG Ratio-1.63
Price to Book (P/B)7.59
Price to Sales (P/S)3.95
P/FCF Ratio83.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)170.16
Revenue Forecast (FY)₹62.60B
Bayer Cropscience India Limited Business Overview & Revenue Model
Company Description
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines ...
How the Company Makes Money
Bayer Cropscience India Limited generates revenue primarily through the sale of agricultural chemicals, including crop protection products such as herbicides and insecticides, as well as seeds and biotechnology products. The company's revenue mode...
Bayer Cropscience India Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
85
Very Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.73B | 54.73B | 51.06B | 51.40B | 47.34B | 42.61B |
| Gross Profit | 21.43B | 20.59B | 21.81B | 23.09B | 20.57B | 17.99B |
| EBITDA | 7.12B | 6.43B | 9.43B | 8.86B | 7.90B | 7.80B |
| Net Income | 6.09B | 5.68B | 7.41B | 7.58B | 6.45B | 4.93B |
Balance Sheet | ||||||
| Total Assets | 51.91B | 52.46B | 45.97B | 46.79B | 43.53B | 42.39B |
| Cash, Cash Equivalents and Short-Term Investments | 7.16B | 9.29B | 12.11B | 9.02B | 8.19B | 12.57B |
| Total Debt | 1.02B | 1.05B | 471.00M | 735.00M | 864.00M | 263.00M |
| Total Liabilities | 20.68B | 23.95B | 17.48B | 19.66B | 18.29B | 16.89B |
| Stockholders Equity | 31.23B | 28.50B | 28.49B | 27.12B | 25.24B | 25.50B |
Cash Flow | ||||||
| Free Cash Flow | -682.00M | 2.59B | 9.06B | 5.32B | 1.60B | 6.45B |
| Operating Cash Flow | -349.00M | 3.00B | 9.52B | 6.09B | 2.15B | 6.87B |
| Investing Cash Flow | -90.00M | 389.00M | 4.00M | 833.00M | 642.00M | 67.00M |
| Financing Cash Flow | -1.84B | -6.10B | -6.56B | -6.13B | -7.03B | -5.56B |
Bayer Cropscience India Limited Technical Analysis
Positive
4508.60
Price Trends
4582.81
Positive
4531.44
Positive
4969.19
Negative
Market Momentum
22.15
Negative
52.47
Neutral
71.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Positive. The current price of 4508.6 is below the 20-day moving average (MA) of 4569.89, below the 50-day MA of 4582.81, and below the 200-day MA of 4969.19, indicating a neutral trend. The MACD of 22.15 indicates Negative momentum. The RSI at 52.47 is Neutral, neither overbought nor oversold. The STOCH value of 71.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BAYERCROP.
Bayer Cropscience India Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹624.15B | 33.00 | ― | 0.50% | 32.88% | 75.74% | |
74 Outperform | ₹436.61B | 39.45 | ― | 0.49% | -5.90% | -14.80% | |
68 Neutral | ₹540.14B | 42.42 | ― | 0.77% | 8.14% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹204.95B | 77.71 | ― | 0.26% | 8.69% | 12.26% | |
60 Neutral | ₹215.93B | 53.52 | ― | 1.57% | 8.92% | 5.06% | |
60 Neutral | ₹186.27B | 8.23 | ― | 2.13% | 19.70% | 22.23% |
* Basic Materials Sector Average
IN:BAYERCROP
Bayer Cropscience India Limited
4,804.65
205.83
4.48%
IN:CHAMBLFERT
Chambal Fertilisers & Chemicals Ltd.
465.00
-159.97
-25.60%
IN:COROMANDEL
Coromandel International Limited
2,115.65
125.83
6.32%
IN:PIIND
PI Industries Limited
2,877.75
-403.14
-12.29%
IN:SUMICHEM
Sumitomo Chemical India Ltd.
410.60
-145.97
-26.23%
IN:UPL
UPL Limited
639.85
31.47
5.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.